The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
ContributorsCourvoisier, Delphine
; Chatzidionysiou, Katarina; Mongin, Denis
; Lauper, Kim
; Mariette, Xavier; Morel, Jacques; Gottenberg, Jacques-Eric; Bergstra, Sytske Anne; Suarez, Manuel Pombo; Codreanu, Catalin; Kvien, Tore K; Santos, Maria Jose; Pavelka, Karel; Hetland, Merete L; Askling, Johan; Turesson, Carl; Kubo, Satoshi; Tanaka, Yoshiya; Iannone, Florenzo; Choquette, Denis; Nordström, Dan C; Rotar, Ziga; Lukina, Galina; Gabay, Cem; Van Vollenhoven, Ronald; Finckh, Axel
Published inRheumatology, vol. 60, no. 2, p. 820-828
Publication date2021
Abstract
Keywords
- ACPA
- PANABA
- TOCERRA
- Anti-citrullinated protein antibodies
- Drug retention
- Rheumatoid arthritis
- Rheumatoid factor
- Seropositivity
Affiliation entities
Citation (ISO format)
COURVOISIER, Delphine et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. In: Rheumatology, 2021, vol. 60, n° 2, p. 820–828. doi: 10.1093/rheumatology/keaa393
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:152634
- DOI : 10.1093/rheumatology/keaa393
- PMID : 32810263
Additional URL for this publicationhttps://academic.oup.com/rheumatology/article/60/2/820/5894051
Journal ISSN1462-0324
